Invention Grant
US09255142B2 Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof
有权
用于诊断上皮衍生的癌症的血标记及其单克隆抗体
- Patent Title: Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof
- Patent Title (中): 用于诊断上皮衍生的癌症的血标记及其单克隆抗体
-
Application No.: US13821844Application Date: 2010-09-09
-
Publication No.: US09255142B2Publication Date: 2016-02-09
- Inventor: Enyun Shen , Yang Song , Shiqi Ren
- Applicant: Enyun Shen , Yang Song , Shiqi Ren
- Applicant Address: CN Beijing
- Assignee: BEIJING COTIMES BIOTECH CO., LTD.
- Current Assignee: BEIJING COTIMES BIOTECH CO., LTD.
- Current Assignee Address: CN Beijing
- Agency: Foley & Lardner LLP
- International Application: PCT/CN2010/001387 WO 20100909
- International Announcement: WO2012/031374 WO 20120315
- Main IPC: C07K16/30
- IPC: C07K16/30 ; G01N33/577 ; C07K16/18 ; G01N33/574 ; G01N33/68
Abstract:
The present invention provides uses of cytokeratins as markers for diagnosing epithelium derived cancers. The present invention provides cancer-related epitopes of cytokeratins and monoclonal antibodies which specifically recognize the epitopes. The present invention also provides methods for the early screen, diagnosis or prognosis of epithelium derived cancers in subjects, methods for the evaluation of therapeutic effect of related medicaments or therapies, and kits for accomplishing the methods.
Public/Granted literature
- US20130260388A1 BLOOD MARKERS FOR DIAGNOSING EPITHELIUM DERIVED CANCERS AND MONOCLONAL ANTIBODIES THEREOF Public/Granted day:2013-10-03
Information query
